Check out our most popular compounded medications! Get Started
7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, 7-Keto-Dehydroepiandrosterone. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance.
The 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules are used to treat various disease states. The specific disease states treated by this formulation will be determined by the prescribing physician based on the patient's individual health needs and medical history.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, 7-Keto-DHEA. This formulation is encapsulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, making it an ideal choice for medications requiring a controlled release profile.
7-Keto-DHEA is a metabolite of the parent hormone, dehydroepiandrosterone (DHEA). It is known for its potential benefits in boosting metabolism, enhancing memory, improving immune function, and promoting weight loss. It is also believed to play a role in reducing the signs of aging and improving overall well-being. However, it's important to note that the effectiveness of 7-Keto-DHEA can vary depending on the individual's health status, age, and other factors.
As a slow-release formulation, the 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules ensure a steady and consistent supply of the active ingredient in the body, thereby maximizing its therapeutic benefits while minimizing potential side effects. This formulation is particularly beneficial for patients who require long-term treatment, as it reduces the need for frequent dosing and improves medication adherence.
Prescribers considering this formulation should be aware of the potential interactions and contraindications associated with 7-Keto-DHEA. It's also important to monitor patient response to therapy and adjust the dosage as necessary to achieve optimal therapeutic outcomes. As with any medication, patient education is key to ensuring safe and appropriate use.
If you have any questions about the 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules or any other formulations, please don't hesitate to reach out to us. Our team of knowledgeable compounding pharmacists at Bayview Pharmacy is always here to assist you.
7-Keto-Dehydroepiandrosterone (7-Keto-DHEA) is a metabolite of the parent hormone dehydroepiandrosterone (DHEA). It is known for its potential benefits in weight management, immune function, and aging. However, like all medications, it may interact with other drugs. It's important to understand these potential interactions to ensure safe and appropriate use of 7-Keto-DHEA.
Firstly, 7-Keto-DHEA may interact with other hormone-related medications. This includes estrogen, progesterone, testosterone, and other steroid hormones. The interaction may alter the effectiveness of these medications or increase the risk of side effects. Therefore, patients taking hormone-related medications should consult their healthcare provider before starting 7-Keto-DHEA.
Secondly, 7-Keto-DHEA may interact with medications that affect liver enzymes, particularly cytochrome P450 enzymes. These enzymes are responsible for metabolizing many drugs. Medications such as antifungals, antibiotics, antiretrovirals, and certain antidepressants may affect these enzymes, potentially altering the metabolism and effectiveness of 7-Keto-DHEA.
Thirdly, 7-Keto-DHEA may interact with medications for thyroid disorders. As 7-Keto-DHEA may increase thyroid hormone levels, it could potentially increase the risk of hyperthyroidism in patients taking thyroid medications. Therefore, patients with thyroid disorders should use 7-Keto-DHEA with caution and under the supervision of a healthcare provider.
Lastly, 7-Keto-DHEA may interact with medications for cardiovascular diseases. As 7-Keto-DHEA may affect heart rate and blood pressure, it could potentially increase the risk of adverse cardiovascular events in patients taking medications for heart disease or high blood pressure.
It's important to note that the slow-release formulation of 7-Keto-DHEA, formulated with Methocel E4M, is designed to release the medication gradually over an extended period of time. This may alter the timing and intensity of potential drug interactions. Therefore, patients and prescribers should consider the unique pharmacokinetic profile of this formulation when assessing potential drug interactions.
Patients should inform their healthcare provider of all medications, supplements, and herbal products they are currently taking to ensure safe and appropriate use of 7-Keto-DHEA. Prescribers should carefully consider the potential for drug interactions when prescribing 7-Keto-DHEA, particularly in patients with multiple medical conditions or those taking multiple medications.
If you have any questions about the potential drug interactions of 7-Keto-DHEA, please reach out to us. We are here to provide you with the most accurate and up-to-date information to support the safe and appropriate medication use.
The 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules work by utilizing a controlled-release polymer known as Methocel E4M. This polymer is designed to gradually release the encapsulated medication or active ingredient over an extended period of time. This slow release mechanism allows for sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
7-Keto-Dehydroepiandrosterone, also known as 7-Keto-DHEA, is a naturally occurring metabolite of the hormone dehydroepiandrosterone (DHEA). DHEA is a hormone produced by the adrenal glands and is a precursor to the sex hormones estrogen and testosterone. 7-Keto-DHEA is not converted into these hormones, but instead, it is involved in many biological functions including cellular production of heat (thermogenesis), metabolism, and the support of various immune functions.
When ingested in the form of our slow-release capsules, 7-Keto-DHEA is gradually released into the body, allowing for a steady and prolonged therapeutic effect. This slow-release mechanism is particularly beneficial for conditions that require a steady supply of the medication over a long period of time, such as certain metabolic disorders, immune system disorders, and conditions related to aging and hormonal imbalance.
By using a slow-release formulation, the frequency of dosing is reduced, which can improve patient compliance. This is particularly beneficial for patients who may have difficulty remembering to take their medication, or for those who prefer the convenience of fewer doses. The slow-release formulation also ensures that the medication is delivered to the body in a controlled manner, reducing the risk of side effects and improving the overall effectiveness of the treatment.
If you have any questions about the 7-Keto-Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this formulation can benefit your specific condition, please do not hesitate to reach out to us. Our team of knowledgeable compounding pharmacists at Bayview Pharmacy is always here to help.
7-Keto-Dehydroepiandrosterone 25mg Slow Release (MEM4) Oral Capsules are a specialized formulation of the 7-Keto-Dehydroepiandrosterone compound encased within a controlled-release capsule. The capsules use Methocel E4M technology, designed to slowly release the encapsulated medication over an extended period.
'Controlled release' technology refers to a system within the capsule that gradually releases the active medication over time. Methocel E4M, the polymer used in these capsules, ensures a slow, steady release, thus maintaining a consistent therapeutic effect.
Slow release capsules are designed to offer sustained therapeutic effects over an extended period. This feature reduces the necessity for frequent dosing and improves patient compliance, especially beneficial for medications requiring a controlled and prolonged release profile.
Methocel E4M is a specific type of controlled-release polymer used in medication capsules. Its function is to control the release of the active ingredient in the medication, ensuring it's gradually released over a specific period, leading to sustained therapeutic benefits.
The main purpose of Methocel E4M technology in this medication is to control the release of 7-Keto-Dehydroepiandrosterone slowly and consistently over an extended period which leads to a prolonged effect of the medication and improved patient compliance.
The frequency of intake should be provided by your healthcare professional based on your individual health status and treatment plan. Due to the slow-release formula, the dosing frequency is usually lower than the immediate-release counterparts.
Yes, slow-release formulations offer advantages such as maintaining a steady level of medication in your system over a prolonged period, reduced dosing frequency, lower risk of medication peaks and troughs, and improved patient convenience and adherence to treatment.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Always consult with your healthcare provider if you have concerns about missed doses.
No, the 7-Keto-Dehydroepiandrosterone 25mg Slow Release capsules should not be opened, crushed, or chewed as this can disrupt the slow-release mechanism. They should be swallowed whole for the intended effect.
Only patients who have been prescribed 7-Keto-Dehydroepiandrosterone 25mg Slow Release capsules by a healthcare professional should take them. As with all medications, it's essential to follow your healthcare provider's guidelines regarding dosage and duration of the treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
